Literature DB >> 29559493

Acute Exudative Polymorphous Vitelliform Maculopathy Syndrome; natural history and evolution of fundal and OCT images over time.

Patrick Murtagh1, Maxwell Treacy1, Kirk Stephenson1, Ian Dooley1.   

Abstract

A 33-year-old man presented with a 10-day history of bilateral blurred vision on a background of a prodromal influenza-like illness. Ocular Coherence Tomography (OCT) and fundal examination coincided with a diagnosis of atypical central serous retinopathy. The patient's symptoms worsened during follow-up, and he was started on steroids. Subsequent fundal examination revealed yellow deposits in a honeycomb pattern and hard exudates in the perimacular region. Serial OCTs revealed progression of bilateral macular intraretinal and subretinal fluid. He was subsequently admitted to hospital for a full paraneoplastic workup. Liaison with our colleagues in other specialist retinal centres led us to a diagnosis of acute exudative polymorphous vitelliform maculopathy syndrome. We subsequently took fundal images to monitor disease progression and to monitor changes seen with autofluorescence in this rare disease entity. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  ophthalmology; retina

Mesh:

Substances:

Year:  2018        PMID: 29559493      PMCID: PMC5878268          DOI: 10.1136/bcr-2018-224241

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  Acute exudative polymorphous paraneoplastic vitelliform maculopathy in a patient with carcinoma, not melanoma.

Authors:  Lili Grunwald; Brad E Kligman; Carol L Shields
Journal:  Arch Ophthalmol       Date:  2011-08

2.  Anti-retinal pigment epithelium antibodies in acute exudative polymorphous vitelliform maculopathy: a new hypothesis about disease pathogenesis.

Authors:  Larry Koreen; Shirley X He; Mark W Johnson; Richard E Hackel; Naheed W Khan; John R Heckenlively
Journal:  Arch Ophthalmol       Date:  2011-01

3.  A case of acute exudative polymorphous vitelliform maculopathy: follow-up and wide-field spectral-domain optical coherence tomography.

Authors:  Domenico Massaro; Alfredo Pece; Francesco Pichi; Lawrence A Yannuzzi; Francesca Gilardoni; Paola Carrai; Francesco Bonsignore; Paolo Nucci
Journal:  Eur J Ophthalmol       Date:  2015-07-30       Impact factor: 2.597

4.  Idiopathic Acute Exudative Polymorphous Vitelliform Maculopathy: Clinical Spectrum and Multimodal Imaging Characteristics.

Authors:  Irene Barbazetto; Kunal K Dansingani; Rosa Dolz-Marco; Alfonso Giovannini; F C Piccolino; Anita Agarwal; Luiz H Lima; Raul N Vianna; Lawrence A Yannuzzi
Journal:  Ophthalmology       Date:  2017-08-23       Impact factor: 12.079

5.  Ocular diseases in metastatic cutaneous melanoma: review of 108 consecutive patients in two German tertiary centers.

Authors:  Rafael S Grajewski; Beatrice Schuler-Thurner; Cornelia Mauch; Nicole Kreuzberg; Konrad R Koch; Antonio Bergua; Claus Cursiefen; Ludwig M Heindl
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-01-22       Impact factor: 3.117

6.  Acute exudative polymorphous vitelliform maculopathy.

Authors:  J D Gass; E L Chuang; H Granek
Journal:  Trans Am Ophthalmol Soc       Date:  1988

7.  Acute exudative polymorphous vitelliform maculopathy syndrome.

Authors:  Clement K Chan; J Donald M Gass; Steven G Lin
Journal:  Retina       Date:  2003-08       Impact factor: 4.256

8.  Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopathy during systemic corticosteroid therapy.

Authors:  J D Gass; H Little
Journal:  Ophthalmology       Date:  1995-05       Impact factor: 12.079

  8 in total
  1 in total

Review 1.  Ocular Paraneoplastic Syndromes.

Authors:  Joanna Przeździecka-Dołyk; Anna Brzecka; Maria Ejma; Marta Misiuk-Hojło; Luis Fernando Torres Solis; Arturo Solís Herrera; Siva G Somasundaram; Cecil E Kirkland; Gjumrakch Aliev
Journal:  Biomedicines       Date:  2020-11-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.